Comparative Evaluation of Nasopharyngeal Swabs for Sampling and Detection of SARS-CoV2
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Covid19
- Sponsor
- Orthopaedic Innovation Centre
- Enrollment
- 169
- Locations
- 2
- Primary Endpoint
- Amount of SARS-CoV2 virus (COVID-19) collected
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The purpose of this trial is to compare 2 types of nasonasopharyngeal swabs (a new design to a conventional nylon-flocked nasopharyngeal swab) for effectiveness.
Detailed Description
Compare the Precision ADM "CanSwab" nasopharyngeal swab to a conventional nylon-flocked nasopharyngeal swab on the basis of: 1. The amount of SARS-CoV2 virus (COVID-19) collected by swabs, measured in CT (thermal cycles) 2. Clinical concordance rate 3. Patient comfort during nasopharyngeal sampling procedure
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years and older
- •Ability to provide informed consent
- •COVID-19 positive cohort only: a previous, positive COVID-19 test in the last 5 days and patient remains symptomatic
- •Exclusion criteria:
- •Malformation of the base of the known skull
- •Active nosebleed before the start of the sample
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Amount of SARS-CoV2 virus (COVID-19) collected
Time Frame: Baseline
amount of SARS-CoV2 virus (COVID-19) collected measured in CT (thermal cycles).
Clinical concordance rate
Time Frame: Baseline
Calculate approximate sensitivity and specificity of the CanSwab to the Flocked swab control.
Patient comfort
Time Frame: Baseline
Patient description of comfort level between the 2 swabs experience measured by "Worse", "Identical" or "Better"